Viewing nowCombinationRosuzet Tablets 10/2.5 mg
Ezetimibe 10mg · Rosuvastatin Calcium 2.6mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202106637 · Approved 2021.09.24 · Insurance code 643508470
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication is used for primary hypercholesterolemia, especially in patients with heterozygous familial and non-familial hypercholesterolemia or mixed dyslipidemia. It effectively lowers total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels in the blood, while increasing HDL cholesterol. This medication helps to safely control blood lipid levels in conjunction with dietary management, making it effective for the prevention and management of cardiovascular diseases.
Administer this medicine once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of this medicine is 10/2.5mg∼10/20mg once daily. The recommended starting dose is 10/2.5mg or 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can rarely cause muscle injury leading to rhabdomyolysis, which can result in a rapid decline in kidney function. Patients showing severe myopathy symptoms or those with conditions that may affect kidney function, such as severe infections, hypotension, major surgery, trauma, or metabolic disorders, should temporarily discontinue or stop using this drug. This medication should not be administered to patients who are allergic to the active ingredient or excipients, patients with liver disease or persistently elevated liver enzyme levels without known cause, patients with muscle diseases, those taking the immunosuppressant cyclosporine, patients with severe renal failure, pregnant or potentially pregnant women, nursing mothers, and those susceptible to myopathy. Patients at elevated risk of myopathy include those with moderate renal impairment, hypothyroidism, a history of genetic muscle disorders, a history of muscle toxicity from statins or fibrates, alcohol abuse, certain races (Asian descent), and those taking fibrate drugs concurrently. Additionally, this medication contains lactose and should not be given to patients with lactose intolerance or related genetic disorders. Caution should be exercised when administering this medication to patients with a history of alcohol abuse or liver conditions, and those with risk factors for myopathy should be closely monitored before and after treatment. If symptoms such as muscle pain, cramps, weakness, fatigue, fever, etc. occur during treatment, medical attention should be sought immediately for tests, and in severe cases, the medication should be discontinued. As liver function may be affected, liver function tests should be conducted before and during treatment, and if liver enzyme levels remain more than three times the normal limit, the dosage should be reduced or stopped. Pregnant or nursing women should not use this medication, and women of childbearing potential should use appropriate contraception during treatment. Safety in children has not been established, and this medication is not recommended for pediatric use. When administered to the elderly, caution should be taken considering the risk of myopathy, and any renal or liver function issues should be discussed with a healthcare professional before treatment. In cases of overdose, no specific antidote exists, requiring symptomatic treatment and monitoring of liver function and muscle enzyme levels. Finally, this medication may interact with other drugs, especially when taken with cyclosporine, fibrates, anticoagulants, etc., and should be carefully managed according to healthcare professional instructions.
muscle pain, pruritus, constipation, discomfort in the upper abdomen, nasopharyngitis, elevated C-reactive protein, lower back pain, facial paralysis, headache, indigestion, hypertension, increased ALT, joint pain, dizziness, itching, rash, urticaria, myopathy, rhabdomyolysis, weakness, angioedema, thrombocytopenia, jaundice, hepatitis, toxic hepatitis, Stevens-Johnson syndrome, eosinophilia and systemic symptoms accompanying drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, cognitive impairment, chest pain, facial edema, strange sensation, drug intolerance, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, positional dizziness, migraine, diabetes, impaired glucose tolerance, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, acute hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, burning sensation in the skin, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, renal impairment, benign esophageal neoplasm, acute kidney failure, oliguria, increased serum creatinine, elevated CK, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, nausea, abdominal pain, diarrhea, loss of appetite, abdominal distension, abnormal liver function tests, fatigue, chest discomfort, generalized edema, diabetic neuropathy, tremors, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, phlegm, runny nose, limb pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness and prevent degradation.
White, oval film-coated tablets
30 tablets/box [10 tablets/PTP x 3], 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Rosuvastatin Calcium 2.6mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.